As of June 2024 OptimizeRx has a market cap of $0.19 Billion. This makes OptimizeRx the world's 6964th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.19 B | -23.09% |
2023 | $0.25 B | -9.86% |
2022 | $0.28 B | -73.89% |
2021 | $1.10 B | 134.43% |
2020 | $0.47 B | 214.91% |
2019 | $0.14 B | 13.43% |
2018 | $0.13 B | 186.75% |
2017 | $45.96 M | 91.23% |
2016 | $24.03 M | -32.14% |
2015 | $35.41 M | 31.82% |
2014 | $26.86 M | 6.98% |
2013 | $25.11 M | 66.47% |
2012 | $15.08 M | 19.44% |
2011 | $12.63 M | 13.21% |
2010 | $11.15 M | -53.48% |
2009 | $23.98 M | -51.78% |
2008 | $49.74 M |
On Jun 16th, 2024 the market cap of OptimizeRx was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Park City Group
PCYG | $0.17 B | -10.84% | ๐บ๐ธ USA |
![]() LivePerson LPSN | $47.78 M | -76.08% | ๐บ๐ธ USA |
![]() Brightcove BCOV | $89.83 M | -55.03% | ๐บ๐ธ USA |
![]() Crexendo CXDO | $82.41 M | -58.75% | ๐บ๐ธ USA |